Related Experiment Video

Updated: May 8, 2025

Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

24.0K

Sclerostin as a new target of diabetes-induced osteoporosis

Yanhua Li1, Yaheng Luo1, Debin Huang1

  • 1Department of Endocrinology and Metabolism, The Third Hospital of Changsha, Changsha, Hunan, China.

Frontiers in Endocrinology
|December 25, 2024
PubMed

Insights

Elevated sclerostin levels are linked to osteoporosis in patients with type 1 and type 2 diabetes. This protein may play a role in diabetes-related bone disease, suggesting it as a potential therapeutic target.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Metabolic Diseases

Background:

  • Sclerostin, a SOST gene product, inhibits WNT signaling and bone formation.
  • Elevated serum sclerostin is observed in osteoporosis patients.
  • Diabetes mellitus, particularly type 1 and type 2, is associated with increased osteoporosis risk.

Purpose of the Study:

  • To review recent advancements in sclerostin research.
  • To explore the role of sclerostin in type 1 and type 2 diabetes-induced osteoporosis.
  • To investigate sclerostin as a potential biomarker and therapeutic target.

Main Methods:

  • Literature review of current research on sclerostin, diabetes, and osteoporosis.
  • Analysis of studies investigating serum sclerostin levels in diabetic patients with and without osteoporosis.
  • Synthesis of findings to propose hypotheses regarding sclerostin's role and predictive value.

Main Results:

  • Patients with type 1 and type 2 diabetes exhibit elevated serum sclerostin levels.
  • Osteoporosis is more prevalent in diabetic patients, correlating with higher sclerostin.
  • Sclerostin is implicated in the pathogenesis of osteoporosis, potentially via glucose metabolism pathways.

Conclusions:

  • Sclerostin may contribute to osteoporosis in type 1 and type 2 diabetes.
  • Serum sclerostin warrants investigation as a predictor for diabetes-induced osteoporosis.
  • Sclerostin presents a potential novel therapeutic target for managing osteoporosis in diabetic patients.
Keywords:
osteoporosispathogenesissclerostintargettype 1 diabetestype 2 diabetes

More Related Videos

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

800
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.3K

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.3K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.5K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.0K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.2K
What is the Skeletal System?01:02

What is the Skeletal System?

Overview
51.8K